Collegium Pharmaceutical
COLL
154 hedge funds and large institutions have $719M invested in Collegium Pharmaceutical in 2021 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 47 increasing their positions, 55 reducing their positions, and 28 closing their positions.
2,736% more call options, than puts
Call options by funds: $312K | Put options by funds: $11K
3% less funds holding
Funds holding: 158 → 154 (-4)
5.28% less ownership
Funds ownership: 107.77% → 102.49% (-5.3%)
14% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 28
15% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 55
20% less capital invested
Capital invested by funds: $898M → $719M (-$178M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
+$14.7M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$4.03M |
| 3 |
CEI
Clark Estates Inc
New York
|
+$3.97M |
| 4 |
SDIC
South Dakota Investment Council
Sioux Falls,
South Dakota
|
+$3.85M |
| 5 |
RA
Royce & Associates
New York
|
+$3.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$23.1M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$16M |
| 3 |
MFIMFI
Mesirow Financial Investment Management - Fixed Income
Chicago,
Illinois
|
-$9.84M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4.67M |
| 5 |
FP
Foundry Partners
Minneapolis,
Minnesota
|
-$4.26M |
COLL Hedge Fund Activity: Q3 2021 in Review
154 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q3 2021, worth a combined $719M — down 20% from $898M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of COLL and 24 opened new positions — a net loss of 4 holders — while 55 trimmed existing stakes and 47 added.
The largest buyer was Peregrine Capital Management, opening a new position worth an estimated $14.7M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $23.1M sold.
- 154 institutional investors held Collegium Pharmaceutical (COLL) as of Q3 2021, down from 158 in Q2 2021.
- Funds reported $719M of Collegium Pharmaceutical stock for Q3 2021, down 20% quarter-over-quarter.
- 24 funds opened new Collegium Pharmaceutical positions in Q3 2021 and 28 closed out, a net change of -4 holders.
- The largest Collegium Pharmaceutical buyer in Q3 2021 was Peregrine Capital Management, an estimated $14.7M added.
- The largest Collegium Pharmaceutical seller in Q3 2021 was Perceptive Advisors, an estimated $23.1M sold.
Based on aggregated 13F filings for Q3 2021.